Stay updated on CaboNivoIpi in Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the CaboNivoIpi in Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CaboNivoIpi in Thyroid Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The study record now shows newer submission and posting dates (November 11 and 13, 2026) in place of the previous July 30 and 31, 2026 dates.
    Difference
    0.1%
    Check dated 2026-11-17T14:38:24.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The study page displays the ClinicalTrials.gov record for a phase II trial of cabozantinib, nivolumab, and ipilimumab for advanced differentiated thyroid cancer, including eligibility, treatment, outcomes, and locations. It also includes posted results-related information and study documents.
    Difference
    98%
    Check dated 2026-11-10T14:26:38.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2; the page remains a 403 error.
    Difference
    0.2%
    Check dated 2026-11-03T15:34:55.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    A sitewide NIH notice about using “Super Intelligence” in place of “Artificial Intelligence” appeared, and the site revision advanced from v3.7.1 to v3.7.2. The study page still displays a 403 error.
    Difference
    1%
    Check dated 2026-10-20T14:57:46.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.0 to v3.7.1, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T14:34:14.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The study page currently displays a 403 Forbidden error, indicating the study record is inaccessible; the content area has been replaced with a standard error page while site chrome remains, preventing access to the study details.
    Difference
    22%
    Check dated 2026-09-29T16:14:26.000Z thumbnail image

Stay in the know with updates to CaboNivoIpi in Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CaboNivoIpi in Thyroid Cancer Clinical Trial page.